ISG Newsletter

Search in ISG

Projects on Iran

● About this project

Human embryonic stem (hES) cells may potentially revolutionize biomedicine through their use as a renewable source of cells for regenerative medicine. However, despite much promise the use and derivation of these cells in many countries is ethically challenging. Interestingly, stem cell research in Iran's Royan Institute is thriving despite many challenges and has led to the generation of novel hES cell lines. Unfortunately, Iranian scientists still have many difficulties to overcome such as inconsistent funding opportunities, sanctions which prevent the import of materials and supplies. This report proposes that the implementation of a governmental agency to promote the development of science as well as improved international relations could potentially eradicate these hurdles and aid in the development of stem cell science in Iran.

by David W.G. Morrison (1) and Ali Khademhosseini (1,2)
(1) Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139.
(2) Center for Biomedical Engineering, Department of Medicine, Brigham and Women?s Hospital, Cambridge, MA, 02139.
Correspondence email:

Click Here for the report